Chicago, ILNCT06477120Now EnrollingIRB Ready

Obesity, Morbid Clinical Trial in Chicago, IL

Access cutting-edge obesity, morbid treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.

Sponsored by University of Illinois at Chicago

Quick Self-Assessment

See if you qualify for this Chicago location

Preparing your pre-screening questions…

Expert Care in Chicago

Access obesity, morbid specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related obesity, morbid treatment provided free

Apply for This Chicago Location

Check if you qualify for this obesity, morbid clinical trial in Chicago, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chicago

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chicago site if eligible
  4. 4Begin participation

About This Obesity, Morbid Study in Chicago

In the United States, a body mass index (BMI) of at least 35.0 kg/m2 affects about 15% of women of reproductive age. Severe obesity is a significant predictor of adverse perinatal outcomes including gestational diabetes mellitus, pre-eclampsia, premature birth, and at its most severe, fetal death, birth defects and a three-fold greater risk of maternal mortality. Observational studies suggest weight maintenance and even modest body fat loss and altering the maternal metabolic milieu (availability of glucose and lipids) in the gestational period may be important to reducing perinatal health risks among pregnant females with severe obesity. The proposed research aims to assess time-restricted eating in the 2nd and 3rd trimesters of pregnancy to explore the effects on maternal weight, and perinatal health outcomes compared to standard clinical care.

Sponsor: University of Illinois at Chicago

Who Can Participate

Inclusion Criteria

Female based on sex assigned at birth
Preconception body mass index (BMI) 35.0 - 60 kg/m2
Singleton pregnancy
Age 18-44 years old
14 - \< = 20 weeks gestational age
Fluency in English to provide consent and complete study procedures
Ability to provide informed consent
Cleared by study doctor and the obstetrician/mid-wife provider to participate
Access to a smartphone to complete intervention procedures

Exclusion Criteria

Deemed medically high risk
Multiple pregnancy (e.g., twins)
Type 1 or 2 diabetes mellitus
Early gestational diabetes (diagnosed at \< = to17 weeks gestational age through an oral glucose tolerance test)
Currently eating ≤ 12 hours daily
Autoimmune disorder (e.g., rheumatoid arthritis)
iron deficiency anemia
Inflammatory bowel disease
Previous spontaneous preterm birth
History of bariatric surgery
Night shift work
Currently incarcerated
Eating disorder

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chicago?

Yes, this clinical trial (NCT06477120) has an active research site in Chicago, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Obesity, Morbid Treatment Options in Chicago, IL

If you're searching for obesity, morbid treatment options in Chicago, IL, this clinical trial (NCT06477120) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced obesity, morbid specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all obesity, morbid clinical trials near you to find additional studies recruiting in your area.

More Obesity Trials in Chicago, IL

See all obesity clinical trials recruiting in Chicago — not just this study.

Browse Obesity Trials in Chicago

Browse More Trials by Condition

Ready to Join in Chicago?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chicago, IL